Found: 1
Select item for more details and to access through your institution.
Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
- Published in:
- Clinical & Translational Oncology, 2018, v. 20, n. 10, p. 1274, doi. 10.1007/s12094-018-1858-8
- By:
- Publication type:
- Article